Intensity Therapeutics Inc. announced the publication in the journal OncoImmunology of results from nonclinical research conducted in partnership with NCI Vaccine Branch under a Cooperative Research and Development Agreement. All results and data reported in the paper were generated at the NCI.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
